Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

SimCorp A/S - Major shareholder announcement

With reference to Section 30 of Consolidated Act no. 377 of 2 April 2020 on capital markets, please be informed that SimCorp A/S January 14, 2021 was informed by SMALLCAP World Funds, Inc.. that SMALLCAP World Funds, Inc. now owns 4.85% of the share capital and voting rights in SimCorp A/S. The shares are traded at NASDAQ Copenhagen A/S. Questions may be addressed to Anders Hjort, VP, Head of Investor Relations, SimCorp A/S (+45 3544 8800). SimCorp A/S

BioStock: Chordate Medical notified on when to resume migraine study

Chordate Medical’s treatment method is currently being evaluated in a migraine study, but due to the pandemic, it has been paused for a fairly long time. Now, however, the company has been notified that the study can be resumed in March after the healthcare professionals at the study clinics in Finland have been vaccinated against Covid-19. The plan is now to recruit the last patient in the study in March, which means that Chordate Medical hopefully will complete the migraine study in July.Read the full article at biostock.se: https://www.biostock.se/en/chordate-medical-notified-on-when-

Elos Medtech appoints Managing Director in Gorlose

Tina Friis-Poulsen has been appointed to succeed Soren Olesen in leading Elos Medtech in Gorlose, Denmark. Tina Friis-Poulsen has been with the company for more than 10 years as Quality and Regulatory Manager and has previously also been leading and responsible for Group QA/RA. Soren Olesen will be handing over responsibility to Tina Friis-Poulsen. Soren Olesen will retain his Dental Business Director role with more focus on, among other things, strategic business development within Elos Medtech and continue reporting to CEO Jan Wahlström. The transition of site leadership

Samsung and Bambuser launch #LiveAtSamsung – releasing new flagship Galaxy S21 in unique partnership with Aftonbladet and Halebop

Friday 15th January 2021 | After a successful partnership for a handful of regional live shopping events over the past six months, Samsung and Bambuser announce today the launch #LiveAtSamsung – an interactive broadcast concept first of its kind, allowing simulcast between brand, retail, and media. At #LiveAtSamsung, viewers will meet knowledgeable experts and beloved ambassadors in exclusive live experiences filled with exciting surprises and offers that one simply does not want to miss. Powered by Bambuser’s proprietary technology, viewers will have the opportunity to

Agenda for Calliditas virtual R&D Day on January 20, 2021

Calliditas Therapeutics AB (publ) (“Calliditas”) (Nasdaq OMX – CALTX; NASDAQ – CALT) today announced the program for the upcoming virtual R&D Day for investors, analysts and journalists on January 20, 2021, which will take place between 1pm and 5pm CET. The R&D Day will feature presentations from executive management and Key Opinion Leaders and will be webcast live and accessible at: https://tv.streamfabriken.com/calliditas-therapeutics-cmd-january-2021.The agenda will be as follows: 1:00pm Introduction & CEO Renée Aguiar-Lucander Corporate overview1:20pm

Sandvik invests in leading AI-powered manufacturing software provider Oqton

Sandvik has acquired a minority stake in the privately owned American software company Oqton, a leading provider of AI-powered manufacturing solutions that allows manufacturers to manage, optimize, and automate their manufacturing workflows.  “This investment is in line with our strategic agenda to broaden our offering in digital manufacturing. We are looking forward to working with Oqton and finding ways to expand our offering for increased customer productivity by creating new products that take advantage of Sandvik’s extensive know-how about manufacturing processes and Oqton’s AI-

Publishing of Valmet's Financial Statement Review 2020 on February 4, 2021

Publishing of Valmet's Financial Statement Review 2020 on February 4, 2021 Valmet Oyj’s press release on January 15, 2021 at 10:00 a.m. EET Valmet's Financial Statement Review 2020 will be published on Thursday, February 4, 2021 at approximately 1:00 p.m. Finnish time (EET). The stock exchange release and presentation material in English and in Finnish will be available at that time on Valmet's website at www.valmet.com/investors. Webcast Valmet will arrange a news conference in English as a live webcast at https://valmet.videosync.fi/2020-q4 

Great interest in Scania's first Green Bond

Scania has now issued its first green bond. About 30 Nordic banks, insurance companies and pension fund managers participated. The bidding resulted in Scania raising loans totalling SEK 1.25 billion with a 4-year maturity for investments that the company is making to convert to production of electric vehicles.It was at the end of 2020 that Scania – as the first pure manufacturer of commercial vehicles – received approval for the company's framework for issuing green bonds. “The great interest in our green bond confirms the financial community’s willingness  to enter into the partnerships

NOTIFICATION OF MANAGERS’ AND CLOSELY RELATED PARTIES’ TRANSACTIONS WITH DAMPSKIBSSELSKABET NORDEN A/S’ SHARES IN CONNECTION WITH SHARE BUY-BACK PROGRAM

ANNOUNCEMENT NO. 12 - 15 JANUARY 2021 In connection with the announced share buy-back program in Dampskibsselskabet NORDEN A/S, A/S Motortramp continuously sells shares pro rata and the market is to be informed accordingly – see the attached file and announcement no. 90/2020. Kind regards, Dampskibsselskabet NORDEN A/S Martin Badsted CFO For further information: Martin Badsted, CFO, tel.: +45 3315 0451

OmniCarService has signed agreements with two car leasing companies, totaling 300 cars

Estimated yearly revenue potential of SEK 1 million, up to SEK 3 million.Our sales team has only been active in the market since December 2020 and taking the COVID-19 situation in Denmark into account, they have been reaching great success in closing deals with two car leasing companies. We estimate a yearly revenue potential of SEK 10 000 per car, it is believed that we during the first year of our agreement will service 33% of the 300 cars which adds up to a sum of SEK 1 million. Potentially, the deal size could reach up to SEK 3 million if we were to service all 300 cars. Since the

Helsinki Airport Development Programme moves forward faster than planned due to the low passenger volumes

In 2020, a total of 5 million (2019: 21.9) passengers travelled from Helsinki Airport, of which 4 million on international routes. The number of passengers at Helsinki Airport fell by a total of 77 per cent from the previous year. In spite of the COVID-19 crisis, Finavia has decided to continue Helsinki Airport Development Programme.International transfer travel, which has enabled the airport's rapid growth in recent years, fell by 80 per cent. The number of passengers with connecting international flights was 713,000 (3,571,900). The number of passengers at Finavia's 21 airports

AcouSort sells AcouTrap system to Japanese distributor

AcouSort has sold an AcouTrap system to its Japanese distributor Physio-Tech. During the autumn 2020, Physio-Tech worked intensively to introduce AcouSort's systems AcouTrap and AcouWash on the Japanese market. Physio-Tech has now purchased an AcouTrap system to meet their increased demand and to quickly be able to offer demos to customers.During the autumn, AcouSort's distributor on the Japanese market has expanded its workforce with a resource dedicated especially to the marketing of AcouSort's systems to Japanese companies and research groups. The effort has been very successful and

Polygiene reports new record sales in the fourth quarter

The Company provides guidance on sales development in the fourth quarter and reports sales of 26.9 (19.0) MSEK, which corresponds to growth of 41.4 %.The Company's wholly owned subsidiary Addmaster Ltd, which was acquired at the beginning of the year, had an even stronger development and increased by as much as 69.2 % (excluding sales to Polygiene) and amounted to 1.7 (1.0) MGBP. Due to the annual report, the entire result hasn’t been completed yet. “It is satisfying to see how we start delivering on the agreements we signed during the year and it’s fantastic to be able to show another

Observe Medical ASA - Doctoral dissertation further demonstrates clinical benefits of Sippi®

Observe Medical ASA, January 15, 2021 – A doctoral (PhD) dissertation at Karolinska Institute, Stockholm, Sweden, demonstrates multiple clinical benefits of the Sippi® automated digital urine meter, and the potential paradigm shift in clinical practice of urine measurement. The PhD thesis ‘Evaluation of an automatic urinometer including use of silicone oil to decrease biofilm formation due to proteinuria, hemoglobinuria and bacterial growth’ is written by Dr. Martin Slettengren and was dissertated at Dept. of Molecular Medicine and Surgery, Karolinska Institute in Stockholm on January 14,

Raisio plc: Managers´ transactions

MANAGERS’ TRANSACTIONS Person subject to the notification requirementName: Himberg Timo KristianPosition: Member of the Supervisory BoardIssuer: Raisio OyjLEI: 74370083282NHIP4QD02 Notification type: INITIAL NOTIFICATIONReference number: 74370083282NHIP4QD02_20210115072705_2____________________________________________ Transaction date: 2020-09-25Venue: NASDAQ HELSINKI LTD (XHEL)Instrument type: SHARENature of the transaction: ACQUISITION Transaction details(1): Volume: 50 Unit price: 3.05 EUR Aggregated transactions(1): Volume: 50 Volume weighted average

Alligator Bioscience appoints Chief Scientific Officer

Lund, Sweden, January 15, 2021 – Alligator Bioscience (Nasdaq Stockholm: ATORX) today announced that the company has appointed Peter Ellmark as Chief Scientific Officer (CSO). Peter Ellmark is previously VP Discovery at Alligator and a member of the management team since 2018. As CSO, Dr. Ellmark takes on the scientific leadership for the company, to further consolidate Alligator's strong position in tumor-directed immunotherapy. Peter Ellmark will be part of the Alligator's executive management team and report to CEO Per Norlén. "Peter's scientific excellence will provide value for our

New strategic recruitments and organizational changes at Enzymatica

To support Enzymatica’s growth journey, Enzymatica  has hired Malin Richter to serve as Director Operations and Kristoffer Ahlerup as Director Commercial for the Enzymatica Group. Both of our new colleagues have long experience from international life science companies such as McNeil, Pharmacia, L’Oréal, Ferrosan and Reckitt Benckiser. Malin will be responsible for production, supply & supply planning, including relationships with CMO (Contract Manufacturing Organizations), as well as D&D – Design & Development. Kristoffer will take responsibility for sales & marketing, international

Invitation to presentation of EQT AB’s Year-End Report 2020

EQT AB’s Year-End Report 2020 will be published on Tuesday 26 January 2021 at approximately 07:00 CET. EQT will host a conference call at 08:30 CET to present EQT AB’s Year-End Report, followed by a Q&A session. The presentation and a video link for the conference call will be available here  from the time of the publication of the Year-End Report. To participate by phone, please use the following dial-in details below, at least 10 minutes in advance. Sweden: +46 856 642 651UK: +44 3333000804USA: +1 6319131422

Soluno launches MyAcademy to accelerate growth and customer satisfaction

Soluno, one of the leading European UCaaS Providers, announces the launch of MyAcademy, a new interactive learning platform.The launch of MyAcademy forms an essential part of Soluno’s overall strategy. The UCaaS service provider is expanding in Europe with a wholesale-first concept and innovates heavily to stay ahead in a competitive market. MyAcademy makes it easier to work with Soluno, who also gets the possibility to offer faster distribution of new and relevant information into different channels. Soluno believes an open mind to training will increase all parties’ opportunities. All

Raytelligence - is listed in Germany

Raytelligence AB's shares will soon be tradeable in Germany at Boerse Stuttgart. Boerse Stuttgart GmbH is the parent company of Nordic Growth Market, the trading venue which is behind the listing initiative. The listing at Boerse Stuttgart is an opportunity to, together with Nordic Growth Market, increase the company's visibility in European capital market In order to support quality pricing in trading at Boerse Stuttgart, the shareholder Swedish Adrenaline AB will grant a share loan to EUWAX AG, who will act as liquidity provider in Raytelligence AB's shares. EUWAX AG is a subsidiary

Scandic comments on market situation and ongoing rent negotiations

In December, Scandic’s average occupancy rate was approximately 15 percent with continued weak demand in all markets. Ongoing rent negotiations have thus far led to agreements for rent reductions and offers from landlords totaling approximately 850 MSEK.In December, Scandic’s average occupancy rate totaled 15 percent, which means that occupancy for the fourth quarter was approximately 23 percent, in line with the company's forecast from December 8. Demand has continued to be weak in all markets and has been impacted by stricter restrictions from authorities. About half of Scandic's hotels

Trading in Metacon AB’s shares commences at Boerse Stuttgart

Metacon AB’s shares will soon be tradeable in Germany at Boerse Stuttgart. Boerse Stuttgart GmbH is the parent company of Nordic Growth Market, the trading venue which is behind the listing initiative. The listing at Boerse Stuttgart is an opportunity to, together with Nordic Growth Market, increase the company’s visibility in European capital marketIn order to support quality pricing in trading at Boerse Stuttgart, the shareholder Lennart Larsson will grant a share loan to EUWAX AG, who will act as liquidity provider in Metacon AB’s shares. EUWAX AG is a subsidiary of Boerse Stuttgart GmbH.

Björn Meltzer new acting head of the business area Large Corporates & Institutions in Swedbank

In 2020, Swedbank has updated the strategic direction. The many changes that the financial industry is undergoing globally are increasing the demand for development. The bank’s work is entering a new phase that includes management changes in the business area Large Corporates & Institutions, where Björn Meltzer will now serve as acting head.“We have updated the strategic direction for Swedbank as a whole,” says Jens Henriksson President and CEO of Swedbank. “Now I want to see a new leadership that can steer Large Corporates & Institutions into the future.” Ola Laurin will step down as

Imfinzi approved in the EU for less-frequent, fixed- dose use in unresectable non-small cell lung cancer

15 January 2021 07:00 GMT Imfinzi approved in the EU for less-frequent, fixed-dose use in unresectable non-small cell lung cancer New option extends dosing from two to four weeks,reducing medical visits and improving patient convenience AstraZeneca's Imfinzi (durvalumab) has been approved in the European Union and the UK for an additional dosing option, a 1,500mg fixed dose every four weeks, in locally advanced, unresectable non-small cell lung cancer (NSCLC) in adults whose tumours express PD-L1 on at least 1% of tumour cells and whose disease has not progressed following

There are no items matching the current filter
There are no more items matching the current filter
Back to top